Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,587,586
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
1,288,743
-
Shares change
-
+6,893
-
Total reported value, excl. options
-
$4,173,688
-
Value change
-
+$25,720
-
Number of buys
-
8
-
Number of sells
-
-7
-
Price
-
$3.24
Significant Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q4 2023
26 filings reported holding ARMP - Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value as of Q4 2023.
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,288,743 shares
of 66,587,586 outstanding shares and own 1.9% of the company stock.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (634,451 shares), VANGUARD GROUP INC (145,078 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (110,382 shares), GEODE CAPITAL MANAGEMENT, LLC (101,013 shares), EDGEWOOD MANAGEMENT LLC (100,000 shares), RENAISSANCE TECHNOLOGIES LLC (53,596 shares), STATE STREET CORP (40,300 shares), Qube Research & Technologies Ltd (23,563 shares), BlackRock Inc. (22,760 shares), and NORTHERN TRUST CORP (19,380 shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.